Early Sun Exposure Linked to Lower Relapse Risk in Children with MS

Naturopathic News

New research suggests that just 30 minutes of daily sun in infancy may reduce disease activity in children with multiple sclerosis.

A study published in Neurology: Neuroimmunology & Neuroinflammation found that children who had at least 30 minutes of daily summer sun exposure in their first year of life were 33% less likely to experience MS relapses. The study also found a 32% reduced relapse risk if the child’s biological mother had similar sun exposure during the second trimester of pregnancy.

Researchers analyzed data from 334 children with MS across 18 U.S. clinics, tracking their sun exposure and relapse rates over several years. They found that only 45% of children with adequate early sun exposure experienced a relapse, compared to 65% of those with less exposure.

While the study does not prove causation, it builds on previous research linking sunlight to lower MS risk and suggests that early sun exposure may have long-term benefits for disease progression. Future research aims to explore the impact of sun exposure at different life stages and its potential role in MS treatment.

Reference: Chang G, et al. Early Sun Exposure and Disease Activity in Childhood-Onset Multiple Sclerosis. Neurology: Neuroimmunology & Neuroinflammation. 2025.

Advertisement

Current Issue

Table of Contents

Air Pollution Disrupted Menstrual Cycles in Premenopausal Women

Air Pollution Disrupted Menstrual Cycles in Premenopausal Women

Common traffic and industrial exhaust gases disrupted estrogen and progesterone cycling, damaged ovarian tissue, and shortened menstrual intervals in premenopausal women, yet environmental exposure history remains absent from standard reproductive health evaluations....

Advertisement

Trending Articles

Thymosin Alpha-1 Restored Immune Function Across Five Organ Systems

Thymosin Alpha-1 Restored Immune Function Across Five Organ Systems

The thymus peptide upregulated 1,198 genes tied to energy metabolism, DNA repair, and cell cycle regulation. The Thymus Shrinks With Age and Takes Immune Function With It The thymus gland loses 95% of its immature immune cells with age, and the peptide it produces to...

Fluoxetine During Development Damaged Hearing and the Brainstem

Fluoxetine During Development Damaged Hearing and the Brainstem

Fluoxetine exposure during early auditory development drove 91 gene expression changes in the brainstem, reduced the stability of mature neural circuits, and left lasting hair-cell damage in the inner ear. Fluoxetine Changed the Developing Auditory Brain and Left the...

Metagenics Names Patrick Sly as CEO to Lead Next Chapter of Growth

Metagenics Names Patrick Sly as CEO to Lead Next Chapter of Growth

Aliso Viejo, CA – December 1, 2025 Metagenics, a leading  doctor-recommended professional supplement announced it has named Patrick Sly as CEO, effective immediately. A highly regarded executive in the health and wellness industry, Mr. Sly brings a wealth of...

FDA Removes Black Box Warnings from Hormone Replacement Therapy

FDA Removes Black Box Warnings from Hormone Replacement Therapy

New review of research shows benefits outweigh risks for women who start treatment within 10 years of menopause onset After more than two decades, the FDA is finally removing the black box warnings that have kept millions of women from accessing hormone replacement...

Custom Publishing

IS TYLENOL SAFE DURING PREGNANCY?

IS TYLENOL SAFE DURING PREGNANCY?

Understanding Risk Factors, Not Causation Learn how much Tylenol pregnant women can safely take, what risk factors matter, and why glutathione status—not acetaminophen itself—determines safety during pregnancy.   IN THIS ARTICLE • Key Takeaways: Tylenol Safety...

Featured News